An expert explained how to foster patients' trust by talking about their gender identity and sexual orientation with the currently preferred wording.
A secondary analysis of the industry-funded EMPULSE trial found that patients with acute heart failure who initiated the sodium-glucose cotransporter-2 inhibitor had improvements in symptoms, physical limitations, and quality of life compared to those who received placebo.
Compared with guideline-based treatment, treatment guided by Gram staining significantly reduced use of broad-spectrum antibiotics and yielded similar clinical responses in patients with ventilator-associated pneumonia (VAP), a Japanese trial found.
One study found increased risk for deep venous thrombosis (DVT) for up to three months after COVID-19, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while another showed low rates of venous thromboembolism (VTE) recurrence in the year after infection.
Data from the National Inpatient Sample and from 11 states showed that diabetes-specific U.S. hospitalizations decreased by 3.1% overall from 2008 to 2016/2017 but increased by 10.5% to 81.5% among patients 18 to 29 years of age.